Oracle Investment Management Inc Y M Abs Therapeutics, Inc. Transaction History

Oracle Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $4.9 Million - $9.25 Million	-315,642 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $412,050 - $559,650	15,000 Added 4.99%	315,642 $9.01 Million
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $2.04 Million - $3.01 Million	-80,000 Reduced 21.02%	300,642 $10.2 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $7.42 Million - $13.2 Million	254,300 Added 201.28%	380,642 $11.5 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $3.83 Million - $5.49 Million	101,130 Added 401.12%	126,342 $6.26 Million
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $362,800 - $902,589	25,212 New	25,212 $658,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.